PathSolutions TotalView
TotalView offers network monitoring as well as root-cause troubleshooting of problems in plain-English. The solution monitors every device as well as every interface on every device. In addition, TotalView goes deep, collecting 19 error counters, performance, configuration, and connectedness so nothing is outside of it’s view. A built-in heuristics engine analyzes this information to produce plain-English answers to problems. Complex problems can now be solved by junior level engineers leaving the senior level engineers to work on more strategic level projects. The core product includes everything needed to run a perfectly healthy network: Configuration management, server monitoring, cloud service monitoring, IPAM, NetFlow, path mapping, and diagramming. Get Total Network Visibility on your network and solve more problems faster.
Learn more
Stack AI
AI agents that interact and answer questions with users and complete tasks using your data and APIs. AI that can answer questions, summarize and extract insights from any long document. Transfer styles and formats, as well as tags and summaries between documents and data sources. Stack AI is used by developer teams to automate customer service, process documents, qualify leads, and search libraries of data. With a single button, you can try multiple LLM architectures and prompts. Collect data, run fine-tuning tasks and build the optimal LLM to fit your product. We host your workflows in APIs, so that your users have access to AI instantly. Compare the fine-tuning services of different LLM providers.
Learn more
Recursion
We are a biotechnology firm in the clinical stage, dedicated to unraveling biological complexities through the integration of cutting-edge innovations spanning biology, chemistry, automation, machine learning, and engineering, all aimed at revolutionizing drug discovery. Our approach allows for enhanced precision in biological manipulation with advanced techniques like CRISPR genome editing and synthetic biology. We also achieve reliable automation for intricate laboratory processes at an unprecedented scale through the use of sophisticated robotics. By employing neural network architectures, we conduct iterative analyses and draw insights from extensive, intricate datasets generated in-house. Furthermore, we are boosting the adaptability of high-performance computing capabilities through cloud-based solutions. Our initiative harnesses new technologies to foster continuous learning cycles around our datasets, establishing us as a next-generation biopharmaceutical enterprise. This is achieved through a harmonious integration of hardware, software, and data, all dedicated to the industrialization of drug discovery. We are transforming the conventional drug discovery pipeline and boast one of the most extensive, diverse, and in-depth pipelines among technology-driven drug discovery companies. Ultimately, our mission is to enhance the efficiency and effectiveness of drug development, paving the way for breakthrough therapies.
Learn more
Atomwise
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Learn more